Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data.
Specenier PM, Van den Weyngaert D, Van Laer C, Weyler J, Van den Brande J, Huizing MT, Dyck J, Schrijvers D, Vermorken JB. Specenier PM, et al. Among authors: van laer c, van den weyngaert d, van den brande j. Ann Oncol. 2007 Nov;18(11):1856-60. doi: 10.1093/annonc/mdm346. Epub 2007 Sep 6. Ann Oncol. 2007. PMID: 17823386 Free article. Clinical Trial.
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert T, Helsen N, Carp L, Hakim S, Martens MJ, Hutsebaut I, Debruyne PR, Maes ALM, van Dinther J, Van Laer CG, Hoekstra OS, De Bree R, Meersschout SAE, Lenssen O, Vermorken JB, Van den Weyngaert D, Stroobants S; ECLYPS investigators. Van den Wyngaert T, et al. J Clin Oncol. 2017 Oct 20;35(30):3458-3464. doi: 10.1200/JCO.2017.73.5845. Epub 2017 Aug 30. J Clin Oncol. 2017. PMID: 28854069 Clinical Trial.
A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Specenier PM, Weyler J, Van Laer C, Van den Weyngaert D, Van den Brande J, Huizing MT, Altintas S, Vermorken JB. Specenier PM, et al. Among authors: van laer c, van den weyngaert d, van den brande j. BMC Cancer. 2009 Aug 6;9:273. doi: 10.1186/1471-2407-9-273. BMC Cancer. 2009. PMID: 19660134 Free PMC article.
Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab.
Szturz P, Specenier P, Van Laer C, Van Den Weyngaert D, Corthouts B, Carp L, Van Marck E, Vanderveken O, Vermorken JB. Szturz P, et al. Among authors: van laer c, van den weyngaert d, van marck e. Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1629-36. doi: 10.1007/s00405-015-3673-y. Epub 2015 Jun 5. Eur Arch Otorhinolaryngol. 2016. PMID: 26044403
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
Schrijvers D, Van Herpen C, Kerger J, Joosens E, Van Laer C, Awada A, Van den Weyngaert D, Nguyen H, Le Bouder C, Castelijns JA, Kaanders J, De Mulder P, Vermorken JB. Schrijvers D, et al. Among authors: van laer c, van den weyngaert d, van herpen c. Ann Oncol. 2004 Apr;15(4):638-45. doi: 10.1093/annonc/mdh145. Ann Oncol. 2004. PMID: 15033673 Free article. Clinical Trial.
The potential of helical tomotherapy in the treatment of head and neck cancer.
Van Gestel D, Verellen D, Van De Voorde L, de Ost B, De Kerf G, Vanderveken O, Van Laer C, Van den Weyngaert D, Vermorken JB, Gregoire V. Van Gestel D, et al. Among authors: van laer c, van den weyngaert d, van de voorde l. Oncologist. 2013 Jun;18(6):697-706. doi: 10.1634/theoncologist.2012-0424. Epub 2013 May 30. Oncologist. 2013. PMID: 23723331 Free PMC article.
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.
Boeckx C, Weyn C, Vanden Bempt I, Deschoolmeester V, Wouters A, Specenier P, Van Laer C, Van den Weyngaert D, Kockx M, Vermorken JB, Peeters M, Pauwels P, Lardon F, Baay M. Boeckx C, et al. Among authors: van laer c, van den weyngaert d. BMC Res Notes. 2014 Jun 4;7:337. doi: 10.1186/1756-0500-7-337. BMC Res Notes. 2014. PMID: 24899223 Free PMC article.
Helical tomotherapy in head and neck cancer: a European single-center experience.
Van Gestel D, Van den Weyngaert D, De Kerf G, De Ost B, Vanderveken O, Van Laer C, Specenier P, Geussens Y, Wouters K, Meulemans E, Cheung KJ, Grégoire V, Vermorken JB. Van Gestel D, et al. Among authors: van laer c, van den weyngaert d. Oncologist. 2015 Mar;20(3):279-90. doi: 10.1634/theoncologist.2014-0337. Epub 2015 Feb 11. Oncologist. 2015. PMID: 25673104 Free PMC article.
Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy.
Soffers F, Helsen N, Van den Wyngaert T, Carp L, Hoekstra OS, Goethals L, Martens M, Deben K, Spaepen K, De Bree R, De Geeter F, Zwezerijnen GJC, Van Laer C, Maes A, Lenssen O, Stroobants S; ECLYPS Investigators. Soffers F, et al. Among authors: van laer c. EJNMMI Res. 2022 Jun 13;12(1):34. doi: 10.1186/s13550-022-00905-y. EJNMMI Res. 2022. PMID: 35695940 Free PMC article.
59 results